HEcoPerMed events and participations
Date |
Event |
10/11/2020 |
Seminar on “Precision Medicine: A Health Economics Perspective” (University of Oslo) |
16-19/11/2020 |
Link to the workshop on “Value-Based and Affordable Precision Medicine: Recommendations for Health Economic Modelling, Innovative R&D Funding and Provider-Payment” at ISPOR Europe 2020 Link to podium talk about “Financing and reimbursement for personalised medicine – are we there yet?” at ISPOR Europe 2020 |
Date |
Event |
HEcoPerMed Contribution |
HEcoPerMed Representative |
28-29/01/2019 |
HEcoPerMed Kick-off meeting (Brussels, BE) |
Presentations/ Discussions |
Consortium |
20-21/06/2019 |
HEcoPerMed Consortium Meeting (Oxford, UK) |
Presentations/ Discussions |
Consortium |
14/10/2019 |
3rd Annual Meeting of the ÖPPM (Austrian Platform for Personalised Medicine) (Vienna, AT) |
Key note “Economic Aspects of PM” |
Apostolos Tsiachristas, University of Oxford |
14/10/2019 |
3rd Annual Meeting of the ÖPPM (Austrian Platform for Personalised Medicine) (Vienna, AT) |
Workshop implementation “Economic Aspects of Per |
Susanne Giesecke/ Manuela Kienegger |
03/11/2019 |
ICPerMed ComEx meeting (Madrid, ES) |
Presentation |
Susanne Giesecke, AIT |
04-05/11/2019 |
ICPerMed Workshop (Madrid, ES) |
Presentation |
Susanne Giesecke, AIT |
02-03/12/2019 |
HEcoPerMed Consortium Meeting (Vienna, AT) |
Presentations/ Discussions |
Consortium |
17-18/02/2020 |
IC2PerMed – Kick Off Meeting |
Participation / Discussions |
Manuela Kienegger |
22-23/06/2020 |
HEcoPerMed Consortium Meeting |
Presentations/ Discussions |
Consortium |
24/09/2020 |
HEcoPerMed Workshop with health economy experts: Guidance and 3 case studies on health economic modelling of personalised medicine (online) |
Presentations/ Discussions |
Consortium |
01/10/2020 |
ICPerMed related CSAs coodinators meeting (online) |
Presentation |
Wolfgang Ballensiefen, DLR |
15-16/10/2020 |
Regions4PerMed CSA Regions4PerMed CSA event ‘Personalising Health Industry’ |
Presentation: Valorising Personalised Medicine and Therapeutics |
Apostolos Tsiachristas, University of Oxford |